Search results
News about Edwards Lifesciences, stock, Q2 2024
News about Edwards Lifesciences, JenaValve Technology, Endotronix
News about Edwards Lifesciences, downgrade, rating
Also in the news
Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring.
2 days ago · About Edwards Lifesciences Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. We are driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape.
Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. Driven by a passion to help patients, the company collaborates with the world’s leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes ...
1 day ago · Edwards Lifesciences has announced strategic acquisitions of JenaValve Technology and Endotronix to expand its structural heart portfolio. These investments aim to address unmet patient needs and ...
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter . [4]
1 day ago · IRVINE, Calif. — IRVINE, Calif. — Edwards Lifesciences Corp. (EW) on Wednesday reported second-quarter profit of $366.3 million. On a per-share basis, the Irvine, California-based company said ...
Edwards Lifesciences is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring.
